Dana-Farber Cancer Institute, U.S.
Colon cancer survival could be extended with physical activity
Published in Cancer Law Weekly, October 7th, 2006
According to recent research from the United States, "Regular physical activity reduces the risk of developing colon cancer, however, its influence on patients with established disease is unknown. We conducted a prospective observational study of 832 patients with stage III colon cancer enrolled in a randomized adjuvant chemotherapy trial. Patients reported on various recreational physical activities approximately 6 months after completion of therapy and were observed for recurrence or death."
"To minimize bias by occult recurrence, we excluded patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2006-10-07)
More Articles from Cancer Law Weekly
- Abiomed
Abiomed receives U.S. FDA approval for implantable artificial heart - Abraxis BioScience
Abraxis provides update on U.S. FDA panel's recommendation for Abraxane trial design - Institute Gustave Roussy, France
Lung tumors effectively treated by radiofrequency ablation - Medizinische Universitat Wien, Austria
Acute myeloid leukemia and myelodysplastic syndrome find new target of 11q amplification in GAB2 - Universitatsklinikum Schleswig-Holstein, Germany
Addition of topotecan to carboplatin-paclitaxel therapy does not improve survival - University of Texas, U.S.
Findings from the United States and United Kingdom describe new data in breast cancer research - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
